Actively Recruiting
Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation
Led by Boston Medical Group · Updated on 2026-01-23
66
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate the effectiveness of pelvic floor therapy in managing erectile dysfunction and premature ejaculation among men experiencing these conditions. The study focuses on whether pelvic floor therapy, which includes electrostimulation, biofeedback, and therapeutic exercise, can improve erectile function and intravaginal latency time in three distinct patient groups: those with premature ejaculation, erectile dysfunction, and both conditions combined. Participants will receive 24 sessions of pelvic floor therapy over 12 weeks. The therapy varies depending on whether the patient has muscular hyperactivity or hypoactivity and includes therapeutic exercises, perineal electromyographic biofeedback, and electrical stimulation. The sessions involve assessments, proprioceptive and coordination work, muscle workouts, functional training, and a final evaluation. During the study, participants will have initial and secondary pelvic floor rehabilitation consultations. Outcomes such as changes in intravaginal latency time and erectile function scores will be measured at 12 weeks, with follow-up assessments at 3 and 6 months. Researchers will also monitor side effects and other related scores throughout the study period, ensuring comprehensive evaluation of therapy impact over time.
CONDITIONS
Brief Title
Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men over 18 years of age
- Erectile dysfunction or premature ejaculation for at least 6 months
- Sexual activity with a heterosexual partner at least once a week
- Signing of informed consent before the start of the study
- Premature ejaculation according to ISSM criteria for premature ejaculation group
- Premature Ejaculation Diagnosis Tool (PEDT) score greater than 11 for premature ejaculation group
- Clinical diagnosis of primary erectile dysfunction for erectile dysfunction group
- International Index Erectile Function - Erectile Function domain (IIEF-EF) score less than 26 for erectile dysfunction group
You will not qualify if you...
- Pharmacological treatment for erectile dysfunction or premature ejaculation in the last 3 months
- Erection Hardness Score (EHS) greater than 3 for patients with erectile dysfunction
- History or suspicion of hypogonadism with AMS score greater than 36 for erectile dysfunction patients
- History of pelvic radiotherapy
- Presence of pacemaker, cardiac arrhythmia, or epilepsy
- History of spinal cord trauma or spinal surgeries
- Inability to attend therapies or control visits
- Illiteracy or cognitive disability preventing questionnaire completion
- Psychiatric, psychological disorders, or cognitive deficiencies
- Injuries in the therapy application area
- Active pelvic organ cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants receive pelvic floor therapy tailored to their condition, including therapeutic exercises, perineal electromyographic biofeedback, and electrical stimulation over 24 sessions.
24 therapy sessions over 12 weeks
Duration - Up to 6 months after treatment
Participants are monitored to assess the lasting effects of pelvic floor therapy on erectile dysfunction and premature ejaculation.
Assessments at 3 and 6 months after therapy completion
Trial Site Locations
Total: 1 location
1
Boston Medical Group Colombia
Bogotá, Cundinamarca, Colombia, 11022
Actively Recruiting
Research Team
C
Carolina Sandoval, Master
H
Héctor Corredor, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here